What are the Emerging Therapies Targeting Platelet-Cancer Interactions?
Recent research has focused on targeting the interactions between platelets and cancer cells to inhibit cancer progression. Therapies that disrupt platelet adhesion to cancer cells or block the release of platelet-derived growth factors are being explored. Moreover, antiplatelet agents, such as aspirin, are being investigated for their potential to reduce cancer metastasis by preventing platelet aggregation around cancer cells. These emerging therapies offer promise in improving cancer outcomes by modulating the role of platelets in cancer biology.
